T1	PROC 136 182	Estudio de extensión abierto y no aleatorizado
T2	PROC 188 234	evaluar la eficacia, seguridad y tolerabilidad
T3	DISO 274 291	glomerulopatía C3
#1	AnnotatorNotes T3	C4087273; C3 glomerulopathy; Disease or Syndrome
T4	CHEM 99 105	LNP023
#2	AnnotatorNotes T4	C4744992; Factor B Inhibitor LNP023; Organic Chemical · Pharmacologic Substance
T5	DISO 316 327	Fallo renal
#3	AnnotatorNotes T5	C0035078; Kidney Failure; Disease or Syndrome | C1565489; Renal Insufficiency; Disease or Syndrome
T6	DISO 354 371	Glomerulopatía C3
#4	AnnotatorNotes T6	C4087273; C3 glomerulopathy; Disease or Syndrome
T7	CHEM 252 258	LNP023
#5	AnnotatorNotes T7	C4744992; Factor B Inhibitor LNP023; Organic Chemical · Pharmacologic Substance
T8	PROC 449 460	tratamiento
#6	AnnotatorNotes T8	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T9	CHEM 369 371	C3
#7	AnnotatorNotes T9	C0009506; Complement 3; Amino Acid, Peptide, or Protein · Immunologic Factor
T10	CHEM 289 291	C3
#8	AnnotatorNotes T10	C0009506; Complement 3; Amino Acid, Peptide, or Protein · Immunologic Factor
T11	DISO 541 555	Comorbilidades
T12	DISO 585 604	enfermedad cardíaca
T13	ANAT 596 604	cardíaca
#9	AnnotatorNotes T13	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T14	DISO 637 667	hipertensión arterial pulmonar
#10	AnnotatorNotes T14	C2973725; Pulmonary arterial hypertension; Disease or Syndrome
T15	DISO 720 736	condición médica
#11	AnnotatorNotes T15	C4745084; Medical Condition; Finding
T16	DISO 707 717	enfermedad
#12	AnnotatorNotes T16	C0012634; Disease; Disease or Syndrome
T17	CHEM 826 832	LNP023
#13	AnnotatorNotes T17	C4744992; Factor B Inhibitor LNP023; Organic Chemical · Pharmacologic Substance
T18	DISO 890 899	infección
#14	AnnotatorNotes T18	C0009450; Communicable Diseases; Disease or Syndrome | C3714514; Infection; Pathologic Function
T19	PROC 920 938	tratamiento médico
#15	AnnotatorNotes T19	C0418981; Medical therapy; Therapeutic or Preventive Procedure
T20	DISO 942 987	Infección crónica por virus de la hepatitis B
T21	DISO 996 1007	hepatitis C
#16	AnnotatorNotes T21	C0019196; Hepatitis C; Disease or Syndrome
T22	DISO 1054 1085	enfermedad de inmunodeficiencia
T23	PROC 1104 1115	diagnóstico
#17	AnnotatorNotes T23	C0011900; Diagnosis; Diagnostic Procedure
T24	PROC 1142 1145	ECG
#18	AnnotatorNotes T24	C1623258; Electrocardiography; Diagnostic Procedure
T25	DISO 109 112	GC3
#19	AnnotatorNotes T25	C4087273; C3 glomerulopathy; Disease or Syndrome
T26	ANAT 322 327	renal
#20	AnnotatorNotes T26	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T27	CHEM 468 475	fármaco
#21	AnnotatorNotes T27	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T28	ANAT 650 658	arterial
#22	AnnotatorNotes T28	C0003842; Arteries; Body Part, Organ, or Organ Component | C1285085; Entire artery; Body Part, Organ, or Organ Component
T29	ANAT 659 667	pulmonar
#23	AnnotatorNotes T29	C0034052; Pulmonary artery structure; Body Part, Organ, or Organ Component | C1269026; Entire pulmonary artery; Body Part, Organ, or Organ Component
T30	DISO 989 992	VHB
#24	AnnotatorNotes T30	C0019163; Hepatitis B; Disease or Syndrome
T31	DISO 1009 1012	VHC
#25	AnnotatorNotes T31	C0019196; Hepatitis C; Disease or Syndrome
T32	DISO 1033 1036	VIH
#26	AnnotatorNotes T32	C0458074; Human immunodeficiency virus (HIV) status; Finding
T33	Date 13 17	2018
T34	Date 82 95	a largo plazo
T36	Date 235 248	a largo plazo
T37	LIVB 262 269	sujetos
#27	AnnotatorNotes T37	C0681850; Study Subject; Group
T38	LIVB 402 411	pacientes
#28	AnnotatorNotes T38	C0030705; Patients; Patient or Disabled Group
T41	LIVB 755 767	investigador
#29	AnnotatorNotes T41	C0035173; Research Personnel; Professional or Occupational Group
T44	LIVB 805 813	paciente
#30	AnnotatorNotes T44	C0030705; Patients; Patient or Disabled Group
T45	LIVB 872 881	Pacientes
#31	AnnotatorNotes T45	C0030705; Patients; Patient or Disabled Group
T46	Duration 952 959	crónica
#32	AnnotatorNotes T46	C0205191; chronic; Temporal Concept
T47	LIVB 964 987	virus de la hepatitis B
#33	AnnotatorNotes T47	C0019169; hepatitis B virus; Virus
T50	Date 1116 1122	actual
T52	LIVB 1206 1213	sujetos
#34	AnnotatorNotes T52	C0681850; Study Subject; Group
T35	DISO 1126 1145	anomalías en el ECG
#35	AnnotatorNotes T35	C2830610; Abnormal electrocardiogram; Finding
T39	PROC 630 634	NYHA
#36	AnnotatorNotes T39	C4706236; Assessment using New York Heart Association Classification; Health Care Activity
T40	PROC 492 498	ensayo
#37	AnnotatorNotes T40	C0008976; Clinical Trials; Research Activity
A1	Status T8 History_of
A2	Status T27 History_of
A3	Status T32 History_of
A4	Status T22 History_of
A5	Status T35 History_of
A6	Status T40 History_of
#38	AnnotatorNotes T2	C0511730; Identify product efficacy and safety issues; Health Care Activity + C3274448; Tolerability Study; Research Activity
#39	AnnotatorNotes T12	C0018799; Heart Diseases; Disease or Syndrome
#40	AnnotatorNotes T20	C0524909; Hepatitis B, Chronic; Disease or Syndrome
#41	AnnotatorNotes T22	C0021051; Immunologic Deficiency Syndromes; Disease or Syndrome
#42	AnnotatorNotes T34	C0443252; Long-term; Temporal Concept
#43	AnnotatorNotes T36	C0443252; Long-term; Temporal Concept
#44	AnnotatorNotes T50	C0521116; Current (present time); Temporal Concept 
T42	Neg_cue 790 797	impedir
T43	Observation 814 820	tolere
A7	Assertion T43 Negated
R1	Negation Arg1:T42 Arg2:T43	
R2	Experiences Arg1:T44 Arg2:T43	
T48	Quantifier_or_Qualifier 821 825	bien
A8	Assertion T48 Negated
R3	Has_Quantifier_or_Qualifier Arg1:T43 Arg2:T48	
R4	Negation Arg1:T42 Arg2:T48	
T49	Observation 835 868	cumpla los requisitos del estudio
A9	Assertion T49 Negated
#45	AnnotatorNotes T49	C1302261; Patient eligible for clinical trial; Finding (?)
R5	Negation Arg1:T42 Arg2:T49	
T51	Observation 1162 1198	riesgo significativo en la seguridad
R7	Experiences Arg1:T52 Arg2:T51	
T53	Neg_cue 167 169	no
T54	Quantifier_or_Qualifier 170 182	aleatorizado
A10	Assertion T54 Negated
R8	Negation Arg1:T53 Arg2:T54	
T55	Quantifier_or_Qualifier 569 575	graves
#46	AnnotatorNotes T55	C1547227; Severe - Severity of Illness Code; Intellectual Product
T56	Quantifier_or_Qualifier 668 673	grave
#47	AnnotatorNotes T56	C1547227; Severe - Severity of Illness Code; Intellectual Product
R9	Has_Quantifier_or_Qualifier Arg1:T14 Arg2:T56	
R10	Location_of Arg1:T29 Arg2:T14	
R11	Location_of Arg1:T28 Arg2:T14	
R12	Location_of Arg1:T13 Arg2:T12	
R13	Has_Quantifier_or_Qualifier Arg1:T11 Arg2:T55	
T57	Result_or_Value 615 623	clase IV
R14	Has_Result_or_Value Arg1:T39 Arg2:T57	
T58	Quantifier_or_Qualifier 675 693	clase IV de la OMS
R16	Location_of Arg1:T26 Arg2:T5	
R17	Has_Quantifier_or_Qualifier Arg1:T1 Arg2:T54	
R18	Experiences Arg1:T37 Arg2:T7	
R19	Experiences Arg1:T37 Arg2:T3	
R20	Overlap Arg1:T2 Arg2:T36	
#48	AnnotatorNotes T58	C4087444; Pulmonary hypertension WHO functional class IV; Intellectual Product
R21	Before Arg1:T16 Arg2:T43	
R22	Before Arg1:T15 Arg2:T43	
R23	Experiences Arg1:T45 Arg2:T18	
R24	Experiences Arg1:T45 Arg2:T19	
T59	Quantifier_or_Qualifier 900 906	activa
#49	AnnotatorNotes T59	C0679217; Active State; Idea or Concept
R25	Has_Quantifier_or_Qualifier Arg1:T18 Arg2:T59	
R26	Causes Arg1:T47 Arg2:T20	
R27	Has_Duration_or_Interval Arg1:T20 Arg2:T46	
R28	Has_Duration_or_Interval Arg1:T30 Arg2:T46	
R29	Has_Duration_or_Interval Arg1:T21 Arg2:T46	
R30	Has_Duration_or_Interval Arg1:T31 Arg2:T46	
R31	Overlap Arg1:T23 Arg2:T50	
R32	Overlap Arg1:T35 Arg2:T24	
R33	Experiences Arg1:T52 Arg2:T35	
R34	Experiences Arg1:T52 Arg2:T24	
#50	AnnotatorNotes T11	C0009488; Comorbidity; Finding
T60	Quantifier_or_Qualifier 556 568	concurrentes
#51	AnnotatorNotes T60	C0205420; Concurrent; Temporal Concept
R35	Has_Quantifier_or_Qualifier Arg1:T11 Arg2:T60	
T61	Quantifier_or_Qualifier 605 613	avanzada
#52	AnnotatorNotes T61	C0205179; Advanced phase; Qualitative Concept
R36	Has_Quantifier_or_Qualifier Arg1:T12 Arg2:T61	
R37	Has_Quantifier_or_Qualifier Arg1:T14 Arg2:T58	
R38	Before Arg1:T11 Arg2:T43	
R39	Before Arg1:T12 Arg2:T43	
R40	Before Arg1:T14 Arg2:T43	
R41	Before Arg1:T11 Arg2:T49	
R42	Before Arg1:T12 Arg2:T49	
R43	Before Arg1:T14 Arg2:T49	
R44	Before Arg1:T16 Arg2:T49	
R45	Before Arg1:T15 Arg2:T49	
T62	Observation 424 460	completado el periodo de tratamiento
#53	AnnotatorNotes T62	C0580352; Treatment completed; Finding
R47	Used_for Arg1:T27 Arg2:T8	
#54	AnnotatorNotes T48	C0205170; Good; Qualitative Concept
R6	Experiences Arg1:T44 Arg2:T17	
R15	Experiences Arg1:T44 Arg2:T15	
R46	Experiences Arg1:T44 Arg2:T16	
R48	Experiences Arg1:T44 Arg2:T14	
R49	Experiences Arg1:T44 Arg2:T12	
R50	Experiences Arg1:T44 Arg2:T11	
A11	Experiencer T37 Patient
A12	Experiencer T38 Patient
A13	Experiencer T41 Other
A14	Experiencer T44 Patient
A15	Experiencer T45 Patient
A16	Experiencer T52 Patient
